Total Funding
35
7
Total FundingSeries A raised
Growth Score 35 in past quarter
-4 pts
Heat Score 7 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2597622
Sompharmaceuticals is a Swiss biopharmaceutical company.
Adrian Daly: Chief Medical Officer
About the Company
Sompharmaceuticals is a Swiss biopharmaceutical company based at the Biopôle in Epalinges-Lausanne, Switzerland. Their focus is on developing novel anti-tumour somatostatin analogue (SSA) peptide medicines and diagnostics for patients with rare diseases, which have unmet medical needs and major market opportunities, including growth hormone
producing pituitary brain tumours (acromegaly) and malignant neuroendocrine hormone producing intestinal and pancreatic tumours (NETs) that are resistant or poorly controlled with currently available SSA treatments, octreotide and lanreotide.

